Willingness-To-Pay for COVID-19 Vaccine in Low and Middle-Income Countries Compared to High-Income Countries: A Systematic Review
Rizka Prita Yuliani, Susi Ari Kristina, Dwi Endarti
Journal of Pharmaceutical Research International · pp. 1–13 · Published 3 Mar 2022
10.9734/jpri/2022/v34i18B35788Abstract
Aims: By focusing largely on lower-income countries, this study adds to the evolving worldwide picture of willingness to pay for COVID19 vaccination. Willingness-To-Pay (WTP) values for the pandemic COVID-19 vaccine, which provide monetary indicators of community preferences for vaccines, could help policymakers in low- and middle-income countries determine priorities for health resource utilization. Study Design: Systematic Review. Methodology: A systematic review of the study on willingness to pay for COVID-19 vaccine in the Pubmed, Science Direct, and Scopus through January 2022 was performed to find relevant articles published between January 2020 and January 2022. Following PRISMA guidelines, the study yielded 19 English-language studies (12 studies in low- and middle-income countries, 2 in high-income countries, and 5 in upper-middle-income countries) that evaluated WTP for COVID-19 vaccines, either existing or hypothetical vaccines. All WTP values extracted were converted to 2021 United States Dollars (USD) for comparability Results: This study showed that the willingness to pay in low-middle-income countries varied from USD 1.2 to USD 85.92. Studies conducted in the same country might have different WTP values. Average WTP in low-income countries have lower WTPs than high and upper-middle-income countries. In addition to being in line with differences in GDP, cases and deaths from COVID-19 in high-income countries are higher than in low-income countries. Conclusion: From low-middle income countries evaluation, the high value of WTP is not consistently aligned with the high value of GDP per capita from each country. The finding demonstrates that the factors that affect the value of WTP are not only the GDP per capita of the country. The perception of risk, the WTP evaluation method used, and several other factors that need to be studied further also affect the amount of WTP.
Cited by 2
Ganesh Bushi, Mahalaqua Nazli Khatib, Renuka Jyothi. S · Immunity, Inflammation and Disease · 2025
Muhammad Salman, Tauqeer Hussain Mallhi, Nida Tanveer · Vaccines · 2022
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
2
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.